Swiss All Share Index
18.715,78
PKT
+357,37
PKT
+1,95
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.06.23 | Roche Sell | Deutsche Bank AG | |
| 22.06.23 | UBS Overweight | JP Morgan Chase & Co. | |
| 22.06.23 | Richemont Overweight | JP Morgan Chase & Co. | |
| 21.06.23 | DocMorris Buy | Warburg Research | |
| 20.06.23 | Roche Sell | Deutsche Bank AG | |
| 16.06.23 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 15.06.23 | Novartis Underweight | Barclays Capital | |
| 15.06.23 | Roche Neutral | UBS AG | |
| 15.06.23 | Novartis Neutral | UBS AG | |
| 14.06.23 | Nestlé Underperform | RBC Capital Markets | |
| 14.06.23 | Nestlé Buy | UBS AG | |
| 13.06.23 | DocMorris Buy | Jefferies & Company Inc. | |
| 13.06.23 | Novartis Buy | Deutsche Bank AG | |
| 12.06.23 | UBS Sector Perform | RBC Capital Markets | |
| 12.06.23 | UBS Buy | Goldman Sachs Group Inc. | |
| 12.06.23 | Givaudan Hold | Deutsche Bank AG | |
| 12.06.23 | Nestlé Buy | Deutsche Bank AG | |
| 12.06.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 09.06.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 09.06.23 | Nestlé Neutral | Credit Suisse Group | |
| 09.06.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 09.06.23 | UBS Buy | Goldman Sachs Group Inc. | |
| 09.06.23 | UBS Overweight | JP Morgan Chase & Co. | |
| 09.06.23 | Holcim Neutral | JP Morgan Chase & Co. | |
| 09.06.23 | DocMorris Sell | UBS AG | |
| 09.06.23 | Novartis Buy | Jefferies & Company Inc. | |
| 09.06.23 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.06.23 | Roche Hold | Jefferies & Company Inc. | |
| 07.06.23 | UBS Overweight | JP Morgan Chase & Co. | |
| 07.06.23 | Nestlé Market-Perform | Bernstein Research | |
| 07.06.23 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 07.06.23 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 06.06.23 | Novartis Buy | Deutsche Bank AG | |
| 06.06.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 05.06.23 | Novartis Neutral | UBS AG | |
| 05.06.23 | Roche Equal Weight | Barclays Capital | |
| 05.06.23 | Novartis Buy | Deutsche Bank AG | |
| 05.06.23 | Novartis Underweight | Barclays Capital | |
| 05.06.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 02.06.23 | Novartis Buy | Jefferies & Company Inc. |